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Abstract
Background: Nucleic acids based therapeutic approaches have gained significant interest in recent years towards the
development of therapeutics against many diseases. Recently, research on aptamers led to the marketing of MacugenH, an
inhibitor of vascular endothelial growth factor (VEGF) for the treatment of age related macular degeneration (AMD).
Aptamer technology may prove useful as a therapeutic alternative against an array of human maladies. Considering the
increased interest in aptamer technology globally that rival antibody mediated therapeutic approaches, a simplified
selection, possibly in one-step, technique is required for developing aptamers in limited time period.
Principal Findings: Herein, we present a simple one-step selection of DNA aptamers against a-bungarotoxin. A toxin
immobilized glass coverslip was subjected to nucleic acid pool binding and extensive washing followed by PCR enrichment
of the selected aptamers. One round of selection successfully identified a DNA aptamer sequence with a binding affinity of
7.58 mM.
Conclusion: We have demonstrated a one-step method for rapid production of nucleic acid aptamers. Although the
reported binding affinity is in the low micromolar range, we believe that this could be further improved by using larger
targets, increasing the stringency of selection and also by combining a capillary electrophoresis separation prior to the one-
step selection. Furthermore, the method presented here is a user-friendly, cheap and an easy way of deriving an aptamer
unlike the time consuming conventional SELEX-based approach. The most important application of this method is that
chemically-modified nucleic acid libraries can also be used for aptamer selection as it requires only one enzymatic step. This
method could equally be suitable for developing RNA aptamers.
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Introduction
In recent years, nucleic acids-based therapy has attracted
significant interest for the treatment of many diseases. It comprises
several approaches based on nucleic acid as the active component,
which include antisense [1,2], ribozymes [2], short interfering
RNA (siRNA) [2–4], microRNA (miRNA) [5,6], and aptamers [7–
11]. Aptamer technology is one of the most promising and
important approaches for therapeutic development. Aptamers are
short single-stranded (ss) DNA or RNA oligonucleotides that can
bind to its target with high affinity and specificity due to their
ability to adopt three-dimensional shapes in solution. These
structured sequence-specific ssDNA or RNA aptamers can
specifically bind to a myriad of different targets [11]. Coupled
with superior storage stability and easy solid-phase production
steps, aptamers have become prime candidates for therapeutic and
diagnostic applications. Furthermore, research on aptamers led to
the marketing of MacugenH, an inhibitor of vascular endothelial
growth factor (VEGF) for the treatment of age related macular
degeneration (AMD) [12].
Traditionally, aptamers are generated by a process referred to
as SELEX (Systematic Evolution of Ligands by Exponential
enrichment) [13–15]. This method is very time consuming and
involves several enzymatic steps. Aptamers composed of natural
DNA and RNA pose some serious limitations such as poor
nuclease resistance and decreased binding affinity. To combat
these problems, chemically modified nucleotides are used.
However, the use of modified nucleotides in SELEX is very
limited because of their poor enzymatic recognition capabilities,
demanding an alternative approach for aptamer selection [16,17].
In addition, the repetitive nature of the SELEX procedure
increases the risk of inducing mutations during the enzymatic
amplifications steps and consequently losing important sequence
information before isolating the high binding aptamers [18].
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We have selected a-bungarotoxin (7984 Da) as the target in our
study. a-Bungarotoxin is one of the toxic components of krait
snake (Bungarus multicinctus) venom. The toxin binds irreversibly
and competitively to the acetylcholine receptor found at the
neuromuscular junction, causing paralysis, respiratory failure and
ultimately death in the victim. Krait snakebite is lethal and often
encountered in Southeast Asia and the Indian subcontinent. The
treatment often becomes difficult unless the snake is properly
spotted and also noted that there is frequently little or no pain at
the site of a krait bite, which can lead to false-reassurance to the
victim [19,20].
Results
One-step Selection on a Glass Coverslip
Our approach of one-step aptamer selection is schematically
illustrated in Figure 1. First, the target a-bungarotoxin was
covalently linked to the surface of a glass coverslip which was
coated with N-hydroxysuccinimide (NHS) functionalized poly-
ethylene glycol (PEG) for reaction with primary amines of the
target. The non-linked sites were blocked with a deactivation
buffer supplied by the manufacturer. The coverslip is very thin and
fragile that makes it difficult to work with. In our experience, it was
best to handle the coverslip on a piece of Parafilm. The nucleic
acid library was first incubated with a deactivated coverslip
without the target peptide to remove the sequences that have
affinity to the surface (negative selection). The remaining unbound
pool was collected and added on to the coverslip immobilized with
a-bungarotoxin and incubated overnight in a humidifying cham-
ber. The coverslip was then washed with a large excess of the
binding buffer and dried by gently blowing N2 gas. The aptamer
binding to the target was monitored directly by fluorescence
microscopy. The absence of high background fluorescence and the
appearance of localized fluorescent spots indicated a successful
aptamer selection against a-bungarotoxin (Figure 2A).
After the initial observation by fluorescence showing aptamer
binding to the toxin, the bound aptamers were eluted by crushing
the glass coverslip well and soaking in water in a 1.5 mL
Eppendorf tube followed by vortexing and heating at 90uC for ten
minutes. The supernatant was collected and PCR amplification
yielded a single band on an agarose gel corresponding to the
expected library size (Figure 2B). The purified PCR product was
later cloned into E.coli and fifty five positive clones were collected
and the purified individual plasmid DNA was sequenced. The
obtained crude sequences were screened and only those sequences,
which retained the initial library design with correct primer
binding regions, were considered for further analyses. Although
most sequences contained a particular motif -GGGC-, we have
only selected the repeating sequences with the motif -GGGC- for
binding studies, which are listed in Table 1.
Aptamer Binding Affinity Determination
The binding interaction between the selected aptamer and a-
bungarotoxin was determined by surface Plasmon resonance
(SPR)-based Biacore 3000 instrument. The selected aptamer
sequences were chemically synthesized which contained a biotin
tag at 59-end. The biotinylated aptamer sequences were then
immobilized on a sensor chip SA (streptavidin coated chip, GE life
sciences). Varying concentrations of a-bungarotoxin (500 nM –
50 mM) was then passed through the surface immobilized with the
aptamer. SPR data showed that the aptamer sequence of clone 24
& 51 can bind to a-bungarotoxin with a KD of 7.5 mM (Figure 3A).
In contrast, aptamer sequences of clones 15, 22 & 42; 28 & 45 and
1 & 16 showed negligible binding (data not shown). We have also
performed non-specific binding analyses using a non-sense target,
insulin. There was no binding observed as expected, even at
higher concentrations.
Discussion
Highly sensitive and specific nucleic acid aptamers against a–
bungarotoxin can be extremely useful as a diagnostic and
therapeutic against krait snake envenomation. Aptamers offer
a unique alternative to the existing antibodies against the toxins
which are much larger, easily degraded, expensive and require the
use of animals for a laborious time consuming production [9,21].
On the other hand, aptamers are easily synthesized and can be
modified with reporter molecules or other nucleotide analogues to
enhance their properties like nuclease resistance. Aptamers also
adopt unique sequence-dependent three-dimensional shapes, so
they are in a sense, shape libraries that may bind to a target based
on their sequence, conformation and/or charge through interac-
tions with binding pockets, hydrogen bonds, stacking of aromatic
rings, van der Waals forces, or a combination of these [21].
Aptamers are normally developed by SELEX, an in vitro evolution
process developed around twenty years ago. Since the invention,
several SELEX protocols employing different selection approaches
have been developed [13,22]. The majority of these modified
protocols still require repetitive selection and enrichment steps for
selecting high affinity aptamers. Considering the increased interest
in aptamer technology globally that rival antibody approach,
a simplified selection, possibly in one-step, technique is required
for developing aptamers in limited time period and to avoid
repeated enzymatic steps that might induce sequence mutations.
In this direction, there are few reports showing the selection of
aptamers in a single step [23–25]. One approach was called
MonoLEX in which a DNA aptamer was selected against the
Vaccinia virus [23]. The technique involved an affinity chroma-
tography step followed by subsequent physical partitioning of the
affinity resin and PCR amplification of the bound aptamers.
Another method to develop aptamers in one step was by using
a combination of atomic force and fluorescence microscopy called
NanoSelection [24]. However, the major problem with this
approach was that the selection was carried out with a very small
pool of randomized preselected thrombin binding aptamer
oligonucleotides unlike a conventional SELEX library and there
was no further report on aptamer selection against new targets by
this approach. Krylov and co-workers reported a Non-SELEX
selection of aptamers using capillary electrophoresis by which they
were able to develop aptamer with affinity in the low micro molar
range [26].
We have developed a one-step method for rapid selection of
aptamers that is simple, cheap and user-friendly. For successful
aptamer selection, three key steps that need to function optimally;
1) efficient separation of the target bound aptamers, 2) enzymatic
amplification by PCR and 3) regeneration of the selected single-
stranded aptamers. One major highlight of our method is that it
eliminates the need for repeated enzymatic amplification and
regeneration of the single-stranded aptamer that always compli-
cate and affect the selection success. In one step selection method,
we have adopted an easy to use glass coverslip for immobilizing
the target for selecting aptamers by monitoring fluorescence under
a microscope to ensure that we are in fact selecting and processing
the target bound aptamer. One-step selection of aptamers on
a glass coverslip is an easy way for generating aptamers even for
a small biomolecular target like a-bungarotoxin (7984 Da) used in
this study. The target immobilization on to the coverslip was
verified by using an Alexa Fluor 555 dye-labeled a-bungarotoxin
DNA Aptamer against a-Bungarotoxin in One Step
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followed by fluorescence microscopy (Figure S1B). A large pool of
fluorescein (FAM) dye–labeled DNA oligonucleotides (100 mL of
40 mM, contains 2.461015 members, the protocol allows using
much larger sized libraries, however, this may increase the
background fluorescence and force non-specific binding) was then
incubated with the target-immobilized coverslip. We speculate
that a stringent washing procedure employed might also account
to a great extent for the successful aptamer identification by this
approach followed by fluorescence microscopy. The coverslip was
later viewed under a microscope and observed the green spots
indicating that we have selected an aptamer. A control experiment
was performed to make sure that we have selected the aptamers
against the intended target peptide immobilized on to the
coverslip. For this purpose, we used the Alexa Flour 555-labeled
a-bungarotoxin and FAM-labeled DNA library and performed the
selection as mentioned. Later, we did overlay the images. A target
specific selection should turn to an orangish-yellow color upon
overlay. If not, both the target and the aptamer will remain as red
and green spots respectively. In our case, we have seen very
distinct orangish-yellow spots upon overlay reassuring the target
specific aptamer selection (Figure S1). Based on this experiment,
we believe that the aptamer was indeed selected specifically to a-
bungarotoxin.
Negative selection using a deactivated coverslip is also
a necessary step prior to the actual aptamer selection against the
target. However, it is important to mention that some of the most
potent binders to a-bungarotoxin that might also have affinity for
the coverslip surface will be removed by this step even before the
actual aptamer selection. But, in this selection protocol this
negative selection is required mainly to avoid the non-specific
surface binding aptamers. Majority of the glass surface binding
aptamers can be removed by this step and other week non-specific
binders can subsequently be washed away by very stringent
washing procedure. To further verify this, we have performed one
selection without performing negative selection using a deactivated
glass coverslip. But in this case, we observed an increased amount
of green fluorescence on the coverslip indicating nonspecific
selection of the aptamers against the glass surface (data not shown).
The binding affinity (KD= 7.52 mM) of the identified aptamer
(from clone 24 & 51, Table 1) against a-bungarotoxin is not very
high. The binding affinity can be improved by truncating the
selected aptamer based on its predicted structure by mfold web
server (Figure 3B) [27]. Although we cannot generalize, we believe
that using our method, the binding affinity can be improved by
adopting various strategies. Using a larger target protein (.15 kD)
may improve the probability in selecting high affinity aptamers to
Figure 1. Single-step selection method. FAM-labeled oligonucleotide library containing a 40 nt random region was incubated with a target
immobilized on a glass coverslip. Unbound sequences were discarded by extensive washing followed by fluorescence microscopy. The coverslip was
later crushed and eluted the bound sequences by heating in water. The selected aptamers were amplified by PCR and cloned into E.coli and the
purified individual plasmid DNA was sequenced.
doi:10.1371/journal.pone.0041702.g001
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some extent because of their structural diversity and immobiliza-
tion efficiency on the coverslip. We also foresee that by combining
capillary electrophoresis [26,28] and our one-step protocol may
yield high affinity aptamers, ie, the target bound aptamer
candidates are first separated by capillary electrophoresis followed
by incubation on the target immobilized coverslip to remove all
week binders monitored by fluorescence microscopy. It is
noteworthy to mention that our selection protocol allows aptamer
selection within 24 hrs, much shorter than a month long
conventional SELEX selection procedure.
In summary, we have demonstrated a simple, rapid one-step
selection protocol for developing nucleic acid aptamers. Using this
method, one DNA aptamer against a-bungarotoxin was identified
with a dissociation constant of 7.5 mM. This method opens up new
ways for aptamer selection in a very limited time at low cost. So
far, the use of important chemically-modified nucleotides in
aptamer selection is limited due to their poor enzymatic
recognition capabilities. Our approach may prove useful especially
for using modified nucleotides containing library-based aptamer
selection. Although we reported a DNA aptamer selection using
this approach, it could equally be suitable for developing RNA
aptamers.
Materials and Methods
All DNA oligonucleotide sequences were purchased from
Integrated DNA technologies (Coralville, USA). The N-hydro-
xysuccinimide activated glass coverslip was purchased from
MicroSurfaces Inc (supplied by Stratech Scientific, Australia).
Phusion DNA polymerase was purchased from New England
Biolabs (supplied by Genesearch Australia). NucleoSpinH Extract
II kit for PCR clean up was purchased from Macherey-Nagel
(supplied by Scientifix Australia). For cloning the PCR product,
the plasmid pCRH-Blunt was purchased from Invitrogen,
Australia. Plasmid DNA was extracted and purified using
a QIAprep Miniprep Kit (purchased from Qiagen, Australia).
Fluorescence microscopy was performed using a Laser Scanning
Microscope (LSM) 710 from Zeiss and a 20x objective at an
excitation wavelength of 488 nm and laser power of 1 mW.
The designed nucleic acid library contained a 40nt random
region flanked by two primer binding regions (59-GGACAG-
GACCACACCCAGCG-40nt-
GGCTCCTGTGTGTCGCTTTGT-FAM-39) and the library
was labeled with a fluorescent tag (FAM) and purchased from
IDT in 1 mmol scale. The library was dissolved in 16PBS
containing 5 mM MgCl2 to yield a concentration of 40 mM and
denatured by heating at 90uC for 5 min followed by cooling in ice.
Before use, the library was kept at room temperature for 15 min to
adjust the temperature.
Single-step Selection on Glass Coverslip
The N-hydroxysuccinimide activated glass coverslip was treated
as per the protocol recommended by the manufacturer. In short,
25 mL of the a-bungarotoxin (125 mM) was dissolved in 30 mL
PBS containing 10% glycerol and applied drop by drop on to the
NHS activated coverslip which was placed on a piece of ParafilmH
M and incubated for 30–40 min at 24uC in a humidifying
chamber. The glass coverslip was then washed with 36200 mL
washing buffer (16PBS containing 0.05% Tween 20) by adding
Figure 2. One-step selection and amplification of the aptamer candidates. A. The observed fluorescence on the toxin immobilized glass
coverslip after washing. The glass coverslip was washed with extensive amounts of binding buffer, effectively removing all nonspecific adhesion to
the coverslip. The pattern of highly localized fluorescent dots and the absence of background smear provide an indication of successful selection; B.
PCR amplification of the eluted bound sequence. Lane 1: Marker DNA, lane 2: Amplified product from the eluted DNA aptamers, lane 3: PCR
amplification without using a template DNA (negative control).
doi:10.1371/journal.pone.0041702.g002
Table 1. Aptamer sequences obtained from the selected
clones.
Clones Sequences
15, 22 & 42 ATCATGTCTTTTCGGGATGGGCAAGAAGGGAAATAATGC
28 &45 AGAAACGTAGCGGTAACTGCTAGAATGCGCCGAGAGAGCG
24 & 51 GCGAGGTGTTCGAGAGTTAGGGGCGACATGACCAAACGTT
1 & 16 AGGGCACAGAGAAGAAGTCGTGGATTTGAATGGTTTTGGT
Only the sequences from the random regions are shown.
doi:10.1371/journal.pone.0041702.t001
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droplets to a piece of ParafilmH M and then by gently placing the
coverslip upside down soaking the coverslip in 200 mL washing
buffer and waiting for 5 min at 24uC. The coverslip was then
placed in 300 mL deactivation buffer (supplied by the manufac-
turer) to block any unreacted groups for 35 minutes in a humid-
ifying chamber. The coverslip were subsequently washed two
times with PBS containing 0.05% Tween 20. After this immobi-
lization step, 120 mL of the prepared library was incubated for
30 min on an inactivated coverslip without a-bungarotoxin
immobilization (negative selection). Then, 100 mL of the count-
er-selected nucleic acid library was transferred to the a-bungar-
otoxin immobilized coverslip and incubated overnight at 24uC in
a humidifying chamber. Extensive washing was then performed
with 4 mL washing buffer (56800 mL), followed by drying the
coverslip by gently blowing nitrogen gas. The backside of the
coverslip was cleaned with a clean tissue soaked in ethanol before
fluorescent imaging by microscopy.
The toxin bound aptamers were later eluted by crushing the
glass coverslip in an Eppendorf tube followed by heating in Milli-
Q water at 90uC for 20 minutes. The resulting solution was
centrifuged at 14000 rpm and the supernatant was collected for
the subsequent PCR amplification step. In short, the PCR mixture
was prepared in a total volume of 50 mL by adding 10 mL 56
Phusion HF buffer (included in the Phusion DNA polymerase kit),
4 mL of dNTPs (400 mM), 28 mL of two times distilled water,
1.5 mL of forward primer (50 mM), 1.5 mL of reverse primer
(50 mM), 5 mL of template (supernatant) and 0.5 mL of Phusion
DNA polymerase (250 U/mL). The reaction mixtures were gently
vortexed and then amplified using a thermal cycler (S1000TM
Thermal cycler, Bio-Rad). A 25-cycle PCR consisted of de-
naturation at 98uC for 10 seconds, annealing at 55uC for
15 seconds and extension at 72uC for 25 seconds. After the
polymerase reactions, gel-loading buffer (included in Ultra Low
DNA size marker kit from Fermentas, supplied by VWR Australia)
was added (1.5 mL) and the products were analysed by 4% agarose
gel electrophoresis followed by UV-photography. The PCR
product was later purified by using the NucleoSpinH Extract II kit.
Cloning and Sequencing
Purified PCR products (50 ng) were cloned into E.coli using
a pCRH-Blunt (Invitrogen) vector according to the manufacturer’s
instructions. Plasmid DNA was extracted using QIAprep (Qiagen)
and sequenced by the Australian Genome Research Facility
(AGRF, Brisbane, Australia).
KD Determination by SPR
The binding affinities of the selected aptamers against a-
bungarotoxin were analyzed by Surface Plasmon Resonance using
a Biacore 3000 Instrument (GE) at 24uC. Streptavidin immobi-
lized sensor chip SA (GE, for Biacore 3000) was used for all
measurements of kinetics and 16PBS binding buffer (137 mM
NaCl, 2.7 mM KCl, 4.2 mM Na2HPO4, 1.47 mM KH2PO4,
0.005% Tween 20) was used as the running buffer. The sensor
chip was preconditioned with 1 mL of the running buffer at a flow
rate of 100 mL/min. Then, the 59-biotinylated aptamer sequences
were immobilized on the chip as recommended by manufacturer’s
manual. Varying concentrations of a-bungarotoxin was then
injected at a flow rate of 30 mL/min for 2 min. The surface was
regenerated by treating with 10 mM NaOH. The KD values were
calculated on the basis of a 1:1 Langmuir binding model by fitting
the association and dissociation rates using the Biacore 3000
evaluation software.
Supporting Information
Figure S1 Fluorescence-based characterization of the a-
bungarotoxin aptamer selection by one-step protocol. A.
An overlay image (orangish-yellow spot indicating aptamer
binding to a-bungarotoxin) of the immobilized a-bungarotoxin
labeled with Alexa Fluor 555 (red colour) and the toxin bound
FAM-labeled DNA aptamer (green fluorescence); B. Character-
Figure 3. Aptamer characterization. A. Binding specificity of the aptamer obtained from clone 24 & 51 by surface plasmon resonance (SPR)
technique using Biacore 3000. Various concentrations of a-bungarotoxin (1, 10, 20, 30, and 40 mM) were passed through the aptamer which was
immobilized on a streptavidin coated sensor chip. The obtained sensorgrams demonstrate the aptamer binding to a-bungarotoxin; B. Predicted
structure of the obtained aptamer using the DNA folding platform from mfold web server [26].
doi:10.1371/journal.pone.0041702.g003
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ization of the a-bungarotoxin labeled with Alexa Fluor 555 (red
colour) immobilized on a glass coverslip; C. a-bungarotoxin bound
FAM-labeled DNA aptamer (green fluorescence).
(TIF)
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